Healthy Skepticism Library item: 3913

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Carey B.
Revisiting Schizophrenia: Are Drugs Always Needed?
New York Times 2006 Mar 21
http://www.nytimes.com/2006/03/21/health/psychology/21schiz.html?ex=1143867600&en=ddbb3ff0f41a7581&ei=5070

Keywords:
schizophrenia

Notes:

Ralph Faggotter’s Comments:

For many years, it has been, and remains, an article of faith in Medicine that schizophrenics must have ongoing treatment with anti-psychotic drugs , started early on in the illness to prevent progressive deterioration.

This believe may be an over-inclusive over-simplification and may need to be modified to accomodate individual variation.

Full text:

THE NEW YORK TIMES
Revisiting Schizophrenia: Are Drugs Always Needed?
By BENEDICT CAREY
March 21, 2006

The only responsible way to manage schizophrenia, most psychiatrists have
long insisted, is to treat its symptoms when they first surface with
antipsychotic drugs, which help dissolve hallucinations and quiet imaginary
voices.

Delaying treatment, some researchers say, may damage the brain.

But a report appearing next month in one of the field’s premier journals
suggests that when some people first develop psychosis they can function
without medication — or with far less than is typically prescribed — as
well as they can with the drugs. And the long-term advantage of treating
first psychotic episodes with antipsychotics, the report found, was not
clear.

The analysis, based on a review of six studies carried out from 1959 to
2003, exposes deep divisions in the field that are rarely discussed in
public.
In the last two decades, psychiatrists have been treating people with
antipsychotic drugs earlier and more aggressively than ever before, even
testing the medications to prevent psychosis in high-risk adolescents.

The studies demonstrate that the drugs are the most effective way to
stabilize people suffering a psychosis. Millions of people rely on them,
and the new report is not likely to alter the way psychiatrists practice
anytime soon.

But some doctors suspect that the wholesale push to early drug treatment
has gone overboard and may be harming patients who could manage with
significantly less medication, perhaps because they have mild forms of the
disorder. About three million Americans suffer from schizophrenia, and a
vast
majority of them take antipsychotic drugs continually or periodically.

‘‘My personal view is that the pendulum has swung too far, and there’s this
knee-jerk reaction out there that says that any period off medication, even
for research, is on the face of it unethical,’‘ said Dr. William Carpenter,
director of the University of Maryland’s Psychiatric Research Center and
the editor of the journal Schizophrenia Bulletin, which will publish the
article on April 1, along with several invited commentaries.

Dr. Carpenter said that while antipsychotics are central to treatment in
most cases the field’s aggressive use of the drugs leaves ‘‘little
maneuvering room’‘ to try different options, like drug-free periods under
close observation after a person’s first episode of psychosis. ‘‘It’s a
very controversial issue, and I thought it was important to get it out
there,’‘ he said.

Other experts warned that the new report’s conclusions were dangerous, and
represented only one interpretation of the evidence.
‘‘I am usually a pretty moderate person,’‘ said Dr. Jeffrey Lieberman,
chairman of psychiatry at Columbia University Medical Center and director
of the New York State Psychiatric Institute. ‘‘But on this I am 110 percent
emphatic: If the diagnosis is clear, not treating with medication is a huge
mistake that risks the person’s best chance at recovery. It’s just flat-out
nuts.’‘

In the report, John Bola, an assistant professor of social work at the
University of Southern California, reviewed six long-term studies involving
623 people who had symptoms of psychosis. All of these men and women entered
the studies soon after their psychosis was diagnosed, after a first or
second break from reality. In the studies, roughly half of the patients were
promptly treated with
antipsychotic drugs while the other half went without the medication for
periods ranging from three weeks to more than six months.
Those who functioned well without medication remained drug free in several
of the studies. Those who relapsed received drug treatment.

Two studies found that after a year or more the patients on a full course
of medication performed better on measures of social interaction, work
success and the risk of rehospitalization than those who were initially
drug-free.

The other four studies found the opposite: that the less-medicated group
did slightly better. Over all, the findings of the studies were a wash,
showing no significant advantage for either group. The patients on full
medication were taking older antipsychotics, like Haldol; similar studies
have not been carried out with newer drugs, like Risperdal.

‘‘The most striking observation in this review,’‘ Dr. Bola wrote in the
paper, ‘‘is the dearth of evidence that addresses the long-term effects of
initial treatment.’‘

Previous reviews concluding that drugs provided significant benefits
included many studies that did not have a comparison group of people who
were not on medication, he found. ‘‘My hypothesis is that there is a
subgroup of patients who are drug-free responders, probably because they
have a mild form the disorder,’‘ Dr. Bola, who has argued against aggressive
drug treatment in the past, said in
an interview. ‘‘I think the implications of this are that we need to be
additionally careful about medicating people after their first psychotic
episode if there’s reason to think they could’‘ function without medication.

Studies suggest that 10 percent to 40 percent of people with symptoms of
psychosis can manage without medication. But there is no test to identify
these people, and psychiatrists say that withholding drugs after a
full-blown psychotic episode is highly risky. Psychotic episodes tend to
become worse over time when untreated, they say, and the effect of the
experience on the brain is still unknown.

‘‘The psychotic state is a crisis, an emergency; people do irrational
things, dangerous things, and the initial treatment has to be with what
works best — medication — along with an attempt to get them into a talking
relationship,’‘ said Dr. Thomas McGlashan, a professor of psychiatry at
Yale.

The issue is most important to patients and their families. First episodes
of psychosis, which often strike in high school or college, can derail young
people at a crucial point in their lives and even lead to suicide. John
Caswell, 50, a writer and an artist living in Lebanon, N.H., said he tried
to kill himself twice after going off medication.

‘‘Once I was driving around and having hallucinations, listening to a gospel
station, and I had this strong feeling that I should die and would wake up
after that and start life anew,’‘ he said in an interview. He purposely
drove his car off the road and into a guardrail, he said.

Since then, Mr. Caswell has managed his symptoms with Risperdal, an
antipsychotic he takes daily. He says he relies on the drug, ‘‘like a
diabetic needs insulin.’‘

Yet a large, study in 2005 comparing the schizophrenia drugs found that over
18 months, about three-quarters of people stopped taking the medications
they were on because they were dissatisfied. The drugs have significant side
effects: older medications can induce Parkinson’s disease-like tremors and
the movement disorder known as tardive dyskinesia; some of the newer drugs
also induce weight gain and increase the risk of diabetes; and in elderly
people, both classes of drugs have
been linked to higher rates of premature death.

Antipsychotic medication also induces significant changes in brain function
that are not well understood. The drugs numb brain cell receptors to the
activity of dopamine, a neural messenger that appears to circulate at high
levels when people are in the grip of psychosis.

Ever adaptable, the body responds by manufacturing more dopamine receptors,
which could make the brain more sensitive to future dopamine onslaughts
that are untreated, experts say.

‘‘Medication can be lifesaving in a crisis, but it may render the patient
more psychosis-prone should it be stopped and more deficit-ridden should it
be maintained,’‘ Dr. McGlashan of Yale wrote in a commentary that
accompanied Dr. Bola’s report.

For these reasons, many former psychiatric patients have challenged the
wisdom of treating psychosis aggressively and early, especially for
high-risk patients who have not yet shown full-blown psychotic symptoms.

‘‘If I had stayed on medication, I don’t think there’s any way my life would
be as together as it is now,’‘ said Will Hall, 40, a mental health advocate
in Northampton, Mass., who was hospitalized 14 years ago and put on
antipsychotics for about four months after a suicide attempt.

Mr. Hall said that he still heard voices, machine sounds and imaginary
conversations but that the hallucinations had become less threatening over
time. ‘‘I am very careful about the early warning signs, the noises, the
sounds,
and I make sure to talk to people and resist the urge to isolate myself,’‘
he said in a telephone interview. ‘‘People can learn tricks, ways of dealing
with symptoms so they don’t get overwhelmed.’‘

Several programs have helped people manage psychotic symptoms with minimal
use of medication. In one, researchers in Finland found that intensive
family therapy helped more than 40 percent of patients with early symptoms
of psychosis recover significantly without antipsychotics — and they have
remained off the drugs, for more than two years.

Another program, in Sweden, also has found that many people do well when
treated with low doses of antipsychotic medications, or none at all, after
their first psychotic break.

But both countries have health care systems in which psychotherapy and
in-hospital care are readily accessible. In the United States,
psychiatrists say, taking patients off medication would leave them
vulnerable to life-altering relapses without sufficient support. Only in
research settings, with carefully informed consent, are doctors likely to
allow people suffering from a first psychosis to go drug free, they say.

‘‘My bottom line is that this is a very challenging illness, every patient
is different, and we need more research to inform decisions about how to
individualize care,’‘ said Dr. John Kane, chairman of the psychiatry
department at Zucker Hillside Hospital in Glen Oaks, N.Y.
With certain patients, he added, ‘‘We have to be very careful about making
blanket statements about which treatment is best.’‘

FAIR USE NOTICE: This may contain copyrighted (C ) material the use of which
has not always been specifically authorized by the copyright owner. Such
material is made available for educational purposes, to advance
understanding of human rights, democracy, scientific, moral, ethical, and
social justice issues, etc. It is believed that this constitutes a ‘fair
use’ of any such copyrighted material as provided for in Title 17 U.S.C.
section 107 of the US Copyright Law. This material is distributed without
profit.